Literature DB >> 20547671

Quinidine interaction with Shab K+ channels: pore block and irreversible collapse of the K+ conductance.

Froylan Gomez-Lagunas1.   

Abstract

Quinidine is a commonly used antiarrhythmic agent and a tool to study ion channels. Here it is reported that quinidine equilibrates within seconds across the Sf9 plasma membrane, blocking the open pore of Shab channels from the intracellular side of the membrane in a voltage-dependent manner with 1:1 stoichiometry. On binding to the channels, quinidine interacts with pore K(+) ions in a mutually destabilizing manner. As a result, when the channels are blocked by quinidine with the cell bathed in an external medium lacking K(+), the Shab conductance G(K) collapses irreversibly, despite the presence of a physiological [K(+)] in the intracellular solution. The quinidine-promoted collapse of Shab G(K) resembles the collapse of Shaker G(K) observed with 0 K(+) solutions on both sides of the membrane: thus the extent of G(K) drop depends on the number of activating pulses applied in the presence of quinidine, but is independent of the pulse duration. Taken together the observations indicate that, as in Shaker, the quinidine-promoted collapse of Shab G(K) occurs during deactivation of the channels, at the end of each activating pulse, with a probability of 0.1 per pulse at 80 mV. It appears that when Shab channels are open, the pore conformation able to conduct is stable in the absence of K(+), but on deactivation this conformation collapses irreversibly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547671      PMCID: PMC2956894          DOI: 10.1113/jphysiol.2010.193128

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  49 in total

1.  Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5.

Authors:  Z Wang; X Zhang; D Fedida
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

2.  Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution.

Authors:  Y Zhou; J H Morais-Cabral; A Kaufman; R MacKinnon
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

3.  Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors.

Authors:  M Zhou; J H Morais-Cabral; S Mann; R MacKinnon
Journal:  Nature       Date:  2001-06-07       Impact factor: 49.962

4.  The open pore conformation of potassium channels.

Authors:  Youxing Jiang; Alice Lee; Jiayun Chen; Martine Cadene; Brian T Chait; Roderick MacKinnon
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

5.  Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect.

Authors:  Shimin Wang; Michael J Morales; Yu-Jie Qu; Glenna C L Bett; Harold C Strauss; Randall L Rasmusson
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

Review 6.  Voltage-gated K channels.

Authors:  Clay M Armstrong
Journal:  Sci STKE       Date:  2003-06-24

7.  Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.

Authors:  Ricardo Caballero; Marc Pourrier; Gernot Schram; Eva Delpón; Juan Tamargo; Stanley Nattel
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Blockade of the delayed rectifier potassium current in Drosophila by quinidine and related compounds.

Authors:  D Kraliz; A Bhattacharya; S Singh
Journal:  J Neurogenet       Date:  1998-01       Impact factor: 1.250

9.  Inhibition of the collapse of the Shaker K+ conductance by specific scorpion toxins.

Authors:  Froylan Gómez-Lagunas; Cesar V F Batista; Timoteo Olamendi-Portugal; Martha E Ramírez-Domínguez; Lourival D Possani
Journal:  J Gen Physiol       Date:  2004-03       Impact factor: 4.086

10.  Na(+) interaction with the pore of Shaker B K(+) channels: zero and low K(+) conditions.

Authors:  F Gómez-Lagunas
Journal:  J Gen Physiol       Date:  2001-12       Impact factor: 4.086

View more
  8 in total

1.  Voltage-dependent biphasic effects of chloroquine on delayed rectifier K(+)-channel currents in murine thymocytes.

Authors:  I Kazama; Y Maruyama; Y Murata; M Sano
Journal:  J Physiol Sci       Date:  2012-02-12       Impact factor: 2.781

2.  A model of the interaction between N-type and C-type inactivation in Kv1.4 channels.

Authors:  Glenna C L Bett; Isidore Dinga-Madou; Qinlian Zhou; Vladimir E Bondarenko; Randall L Rasmusson
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

3.  Mibefradil inhibition of the Cole-Moore shift and K+-conductance of the tumor-related Kv10.1 channel.

Authors:  F Gómez-Lagunas; C Barriga-Montoya
Journal:  Channels (Austin)       Date:  2017-06-26       Impact factor: 2.581

4.  Shab K (+) channel slow inactivation: a test for U-type inactivation and a hypothesis regarding K (+) -facilitated inactivation mechanisms.

Authors:  Elisa Carrillo; Imilla I Arias-Olguín; León D Islas; Froylan Gómez-Lagunas
Journal:  Channels (Austin)       Date:  2013-02-18       Impact factor: 2.581

5.  Interaction of local anesthetics with the K (+) channel pore domain: KcsA as a model for drug-dependent tetramer stability.

Authors:  Noel W Gray; Boris S Zhorov; Edward G Moczydlowski
Journal:  Channels (Austin)       Date:  2013-04-01       Impact factor: 2.581

6.  Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone.

Authors:  T A Meléndez; A Huanosta-Gutiérrez; C Barriga-Montoya; M González-Andrade; F Gómez-Lagunas
Journal:  Pflugers Arch       Date:  2020-01-02       Impact factor: 3.657

7.  K⁺-dependent selectivity and external Ca²⁺ block of Shab K⁺ channels.

Authors:  Elisa Carrillo; Lucero Pacheco; Daniel Balleza; Froylan Gomez-Lagunas
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Conductance stability and Na+ interaction with Shab K+ channels under low K+ conditions.

Authors:  Froylán Gómez-Lagunas; Elisa Carrillo; Carolina Barriga-Montoya
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.